FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2508662911> ?p ?o ?g. }

• W2508662911 abstract "Infection of dogs with the cardiopulmonary nematode Angiostrongylus vasorum may result in severe clinical disease therefore adequate prevention is necessary. A randomized, negative control, blinded study was conducted to evaluate the efficacy in the prevention of canine A. vasorum infection after monthly administrations of NexGard Spectra®, a novel chewable tablet formulation combining the insecticide and acaricide afoxolaner and the anthelmintic milbemycin oxime, in a multiple challenge (trickle infection) model. Twenty beagle dogs were challenged orally with doses of approximately 32–43 third-stage larvae of A. vasorum once every other week on seven occasions (Study Days -7, 7, 21, 35, 49, 63 and 77). Ten dogs were administered NexGard Spectra® as close as possible to the minimum recommended dose of afoxolaner and milbemycin oxime, i.e. 2.5 mg/kg body weight and 0.5 mg/kg body weight, respectively, four times at monthly intervals (Study Days 0, 28, 56 and 84) while the remaining ten dogs served as untreated controls. For parasite recovery and count, dogs were euthanized humanely and necropsied six to eight days following the last treatment (Study Days 90–92). Beginning six weeks after first inoculation, faeces were collected on a bi-weekly basis and examined for first-stage larvae of A. vasorum. Untreated dogs harboured 39–95 adult A. vasorum (geometric mean, 66.4), while zero to 24 adult A. vasorum were recovered from the treated dogs (geometric mean, 3.4; P < 0.0001). Thus, efficacy of NexGard Spectra® administered at monthly intervals against incoming A. vasorum was 94.9 %. Compared to the untreated controls, larval excretion of the treated dogs was reduced by 99.9 % (P < 0.0001). Results of this study demonstrate that NexGard Spectra®, when administered at monthly intervals, can effectively prevent canine A. vasorum infection." @default.
• W2508662911 created "2016-09-16" @default.
• W2508662911 creator A5009850136 @default.
• W2508662911 creator A5023785445 @default.
• W2508662911 creator A5029163481 @default.
• W2508662911 creator A5031808429 @default.
• W2508662911 creator A5033428549 @default.
• W2508662911 creator A5035381303 @default.
• W2508662911 creator A5049051331 @default.
• W2508662911 creator A5065736188 @default.
• W2508662911 creator A5070777077 @default.
• W2508662911 date "2016-09-02" @default.
• W2508662911 modified "2023-10-17" @default.
• W2508662911 title "Monthly administrations of milbemycin oxime plus afoxolaner chewable tablets to prevent Angiostrongylus vasorum infection in dogs" @default.
• W2508662911 cites W1582827183 @default.
• W2508662911 cites W1615161434 @default.
• W2508662911 cites W1969351561 @default.
• W2508662911 cites W1975565920 @default.
• W2508662911 cites W1987034121 @default.
• W2508662911 cites W1996780737 @default.
• W2508662911 cites W2001002464 @default.
• W2508662911 cites W2003536853 @default.
• W2508662911 cites W2005291050 @default.
• W2508662911 cites W2008791967 @default.
• W2508662911 cites W2021218340 @default.
• W2508662911 cites W2027972386 @default.
• W2508662911 cites W2029188300 @default.
• W2508662911 cites W2030394801 @default.
• W2508662911 cites W2061354930 @default.
• W2508662911 cites W2067005049 @default.
• W2508662911 cites W2085545098 @default.
• W2508662911 cites W2126079065 @default.
• W2508662911 cites W2141389858 @default.
• W2508662911 cites W2145850948 @default.
• W2508662911 cites W2217802483 @default.
• W2508662911 cites W2259493269 @default.
• W2508662911 cites W2294761363 @default.
• W2508662911 cites W2307850201 @default.
• W2508662911 cites W2400619970 @default.
• W2508662911 cites W2417438220 @default.
• W2508662911 cites W2534455593 @default.
• W2508662911 cites W4213276193 @default.
• W2508662911 doi "https://doi.org/10.1186/s13071-016-1773-1" @default.
• W2508662911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5010729" @default.
• W2508662911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27589951" @default.
• W2508662911 hasPublicationYear "2016" @default.
• W2508662911 type Work @default.
• W2508662911 sameAs 2508662911 @default.
• W2508662911 citedByCount "17" @default.
• W2508662911 countsByYear W25086629112016 @default.
• W2508662911 countsByYear W25086629112017 @default.
• W2508662911 countsByYear W25086629112018 @default.
• W2508662911 countsByYear W25086629112019 @default.
• W2508662911 countsByYear W25086629112020 @default.
• W2508662911 countsByYear W25086629112021 @default.
• W2508662911 countsByYear W25086629112022 @default.
• W2508662911 crossrefType "journal-article" @default.
• W2508662911 hasAuthorship W2508662911A5009850136 @default.
• W2508662911 hasAuthorship W2508662911A5023785445 @default.
• W2508662911 hasAuthorship W2508662911A5029163481 @default.
• W2508662911 hasAuthorship W2508662911A5031808429 @default.
• W2508662911 hasAuthorship W2508662911A5033428549 @default.
• W2508662911 hasAuthorship W2508662911A5035381303 @default.
• W2508662911 hasAuthorship W2508662911A5049051331 @default.
• W2508662911 hasAuthorship W2508662911A5065736188 @default.
• W2508662911 hasAuthorship W2508662911A5070777077 @default.
• W2508662911 hasBestOaLocation W25086629111 @default.
• W2508662911 hasConcept C126322002 @default.
• W2508662911 hasConcept C165901193 @default.
• W2508662911 hasConcept C203014093 @default.
• W2508662911 hasConcept C2775883059 @default.
• W2508662911 hasConcept C2776186584 @default.
• W2508662911 hasConcept C2776820430 @default.
• W2508662911 hasConcept C2776908094 @default.
• W2508662911 hasConcept C2778622360 @default.
• W2508662911 hasConcept C33070731 @default.
• W2508662911 hasConcept C42972112 @default.
• W2508662911 hasConcept C71924100 @default.
• W2508662911 hasConcept C74714110 @default.
• W2508662911 hasConcept C86803240 @default.
• W2508662911 hasConceptScore W2508662911C126322002 @default.
• W2508662911 hasConceptScore W2508662911C165901193 @default.
• W2508662911 hasConceptScore W2508662911C203014093 @default.
• W2508662911 hasConceptScore W2508662911C2775883059 @default.
• W2508662911 hasConceptScore W2508662911C2776186584 @default.
• W2508662911 hasConceptScore W2508662911C2776820430 @default.
• W2508662911 hasConceptScore W2508662911C2776908094 @default.
• W2508662911 hasConceptScore W2508662911C2778622360 @default.
• W2508662911 hasConceptScore W2508662911C33070731 @default.
• W2508662911 hasConceptScore W2508662911C42972112 @default.
• W2508662911 hasConceptScore W2508662911C71924100 @default.
• W2508662911 hasConceptScore W2508662911C74714110 @default.
• W2508662911 hasConceptScore W2508662911C86803240 @default.
• W2508662911 hasIssue "1" @default.
• W2508662911 hasLocation W25086629111 @default.
• W2508662911 hasLocation W25086629112 @default.
• W2508662911 hasLocation W25086629113 @default.
• W2508662911 hasLocation W25086629114 @default.
• W2508662911 hasOpenAccess W2508662911 @default.
• W2508662911 hasPrimaryLocation W25086629111 @default.

• next